Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary

Acta Endocrinol (Copenh). 1984 Dec;107(4):471-5. doi: 10.1530/acta.0.1070471.

Abstract

Transfrontal hypophysectomy was performed in a patient with Cushing's disease and gross enlargement of the pituitary. Despite some reduction of cortisol production active Cushing's syndrome remained due to the presence of a tumour remnant. Medical treatment with the GABA-transaminase inhibitor sodium valproate induced hypocorticism necessitating corticosteroid substitution therapy. Nine months after sodium valproate withdrawal hypercorticism was documented. Re-institution of sodium valproate treatment induced hypocorticism again. As sodium valproate is known to induce a decrease of plasma ACTH in Nelson's syndrome, it is proposed that large tumours present at the time of diagnosis and those appearing after adrenalectomy may represent the spectrum of a single disorder. A prospective trial to study the effects of sodium valproate and other neurotransmitter modulating agents on the size and endocrine function of ACTH secreting macroadenomas is urgently needed.

Publication types

  • Case Reports

MeSH terms

  • 17-Hydroxycorticosteroids / urine
  • Adenoma / blood
  • Adenoma / complications*
  • Adrenocorticotropic Hormone / blood
  • Cushing Syndrome / blood
  • Cushing Syndrome / complications
  • Cushing Syndrome / drug therapy*
  • Female
  • Humans
  • Hydrocortisone / blood
  • Middle Aged
  • Pituitary Neoplasms / blood
  • Pituitary Neoplasms / complications*
  • Valproic Acid / therapeutic use*

Substances

  • 17-Hydroxycorticosteroids
  • Valproic Acid
  • Adrenocorticotropic Hormone
  • Hydrocortisone